Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan

Kuo, Shuenn‐Wen; Shih, Shu Man; Chien, Li Hsin; Hsiung, Chao A.

doi:10.3201/eid2608.201192

Cited by 118 publications

(103 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The positive rate for influenza exhibited a sharp decrease after interventions for COVID-19 were imposed in late January and reached a shallow level within several weeks. A similar phenomenon for influenza was also observed in Taiwan and Singapore [ [9] , [10] ]. For the past three seasons, after the positive rate reached its peak, there was possibly a slight decrease, but it remained at a high level for a relatively long time.…”

supporting

confidence: 78%

Influenza activity during the outbreak of coronavirus disease 2019 in Chinese mainland

Liu¹,

Deng²,

Wang³

et al. 2020

Biosafety and Health

View full text Add to dashboard Cite

Since coronavirus disease 2019 (COVID-19) might circulate in the following seasons, it is essential to understand how COVID-19 influences other respiratory diseases, especially influenza. In this study, we analyzed the influenza activity from mid-November 2019 to March 2020 in mainland China and found that the influenza season ended much earlier than previous seasons for all subtypes and lineages, which may have resulted from the circulation of COVID-19 and measures such as travel control and personal protection. These findings provide rudimentary knowledge of the co-circulation patterns of the two types of viruses.

show abstract

supporting

confidence: 78%

Influenza activity during the outbreak of coronavirus disease 2019 in Chinese mainland

Liu¹,

Deng²,

Wang³

et al. 2020

Biosafety and Health

View full text Add to dashboard Cite

show abstract

“…Of the 23 included studies, the results related to comparative seasons are presented. The majority of the studies (n=18) describe results from the Asian region [21][22][23][24][26][27][28][29][30][31]33,34,36,[39][40][41]43], 9 from North America [21,27,28,32,37,38,[41][42][43] and 5 from Europe [21,25,27,28,41]. The observation period of the studies in the 2020 season ends in the 8 th [26] to 21 st [38] calendar week.…”

Section: Characteristics Of Included Studiesmentioning

confidence: 99%

Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden – a systematic review

Fricke

Glöckner

Dreier

et al. 2021

Journal of Infection

117

102

View full text Add to dashboard Cite

“…The necessary physical distancing policies are likely to negatively affect active case finding as well as community-based activities which are important to manage TB (and HIV) in high TB burden countries [ 216 ]. However, they may reduce transmission of TB, which has already been shown for influenza [ 217 , 218 ]. Both clinical and programmatic approaches to TB treatment are also affected in high-burden countries and drug procurement (particularly for second-line drugs) is also likely to suffer.…”

Section: Lessons On Covid-19 and Tb: Lessons Learned And Common Solutmentioning

confidence: 99%

Epidemic and pandemic viral infections: impact on tuberculosis and the lung

et al. 2020

View full text Add to dashboard Cite

Major epidemics including some that qualify as pandemics, such as Severe Acute Respiratory Syndrome (SARS), Middle-Eastern Respiratory Syndrome (MERS), Human Immunodeficiency Virus, pandemic H1N1/09 and most recently COVID-19 affect the lung. Tuberculosis (TB) remains the top infectious disease killer but apart from the TB-HIV syndemic, little is known regarding the interaction of viral epidemics and pandemics with TB. The aim of this consensus-based document is to describe the effects of the viral infections resulting in epidemics and pandemics that affect the lung (MERS, SARS, HIV, influenza A (H1N1)pdm/09 and COVID-19) and their interactions with TB. A search of the scientific literature was performed. A writing committee of international experts including the European Centre for Disease Prevention and Control Public Health Emergency (ECDC PHE) team, the World Association for Infectious Diseases and Immunological Disorders (WAidid), the Global Tuberculosis Network (GTN) and members of ESCMID Study Group for Mycobacterial Infections (ESGMYC) was established. Consensus was achieved after multiple rounds of revisions between the writing committee and a larger expert group. A Delphi process involving the core group of authors, excluding the ECDC PHE team identified the areas requiring review/consensus, followed by a second round to refine the definitive consensus elements. The epidemiology, immunology of these viral infections and their interactions with TB are discussed with implications on diagnosis, treatment and prevention of airborne infections (infection control, viral containment and workplace safety). This consensus document represents a rapid and comprehensive summary on what is known on the topic.

show abstract

Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan

Cited by 118 publications

References 5 publications

Influenza activity during the outbreak of coronavirus disease 2019 in Chinese mainland

Influenza activity during the outbreak of coronavirus disease 2019 in Chinese mainland

Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden – a systematic review

Epidemic and pandemic viral infections: impact on tuberculosis and the lung

Contact Info

Product

Resources

About